Opendata, web and dolomites
H2020 projects about "malignancies"
The page lists 78 projects related to the topic "malignancies".
| # | |||
|---|---|---|---|
| 1 | SPENmr | Ultrafast Spatiotemporally-Encoding: A Superior Approach to Cancer Diagnosis by Non-Invasive Diffusion-Weighted MRI | 2015 |
| 2 | MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time | 2015 |
| 3 | BeyondSeq | Genomic diagnostics beyond the sequence | 2015 |
| 4 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 5 | TRANSCAN-2 | ERA-NET: Aligning national/regional translational cancer research programmes and activities | 2015 |
| 6 | AutophagosomeSealing | Ymr1 role in the Atg proteins release from complete autophagosomes | 2015 |
| 7 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 8 | SFSASP | Structural and Functional Studies of ATRX- Syndrome Protein | 2015 |
| 9 | TITLY | Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma | 2015 |
| 10 | URO-BEST | UROthelial carcinoma Biomarker based diagnostic tEST | 2015 |
| 11 | BI-MARK | Clinical validation of the CD32b biomarker on the European market | 2015 |
| 12 | ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer | 2015 |
| 13 | HaemMetabolome | Deciphering the Metabolism of Haematological Cancers | 2015 |
| 14 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 15 | TRANSBIO | A BIOmarker-based assay for prognosis and monitoring in renal TRANSplantation | 2015 |
| 16 | CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies | 2016 |
| 17 | PIBD-SETQuality | Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care | 2016 |
| 18 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 19 | SLIM | Synthetic Lethal Interactions with nucleophosMin 1 | 2016 |
| 20 | ANGIO-IMAGE | ANGIO-tracer for immuno-PET imaging: a stratification and monitoring tool for anti-angiogenesis treatment | 2016 |
| 21 | BCM-UPS | Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies | 2016 |
| 22 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 23 | MARS | Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach | 2017 |
| 24 | TRANSBIO | Cellular BIOtechnology for prognosis and monitoring in renal TRANSplantation | 2017 |
| 25 | HbMP-700 | The World's First Safe and Efficacious Human Blood Substitute: HbMP-700, a Haemoglobin based oxygen carrier, based on bovine blood. | 2017 |
| 26 | INNOBCT | Innovative combination therapy against bladder cancer | 2017 |
| 27 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 28 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 29 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 30 | HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | 2017 |
| 31 | Prolifimeter | Growth detection and quantification (GDQ) | 2017 |
| 32 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 33 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 34 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 35 | CTC4BMP | Circulating tumor cells for tailoring BMP targeted therapies | 2017 |
| 36 | OR-HMC | Assay for cancer diagnostics by quantification of 5hmC | 2017 |
| 37 | StroMaP | Stromal stress networks underlying phenotypic plasticity and tumor fitness | 2017 |
| 38 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 39 | CENTR-ALL | Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) | 2019 |
| 40 | LEUKEYOLK | Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis | 2019 |
| 41 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 42 | INTEPOL | Elucidating polarity pathways in the fly and murine intestinal epithelium | 2018 |
| 43 | SKIN SUBSTITUTE | Development of hybrid artificial skin substitute for chronic diabetic wounds | 2018 |
| 44 | LANTERNS | LANTHANIDE ION DOPING OF TERNARY QUANTUM DOTS | 2019 |
| 45 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 46 | TARGETSS | Targeting SWI/SNF complex function in cancer | 2019 |
| 47 | SLAMseq | SLAMseq: Temporal resolution in gene expression profiling across multiple platforms | 2019 |
| 48 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 49 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 50 | SCIPER | Studying Cancer Individuality by Personal and Predictive Drug Screening and Differential OMICs | 2018 |
| 51 | LeukemiaEnviron | SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA | 2019 |
| 52 | CLOSER | Childhood Leukemia: Overcoming distance between South America and Europe Regions | 2019 |
| 53 | ESCALON | European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | 2019 |
| 54 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 55 | GLADIATOR | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | 2019 |
| 56 | ImmuNiche | Identifying spatial determinants of immune cell fate commitment | 2019 |
| 57 | MyPal | MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems | 2019 |
| 58 | PATRES-MDS | Pathogenesis and treatment of splicing factor mutant myelodysplastic syndromes | 2019 |
| 59 | Visual Proteomics | Biomarker discovery by AI-guided, image based single-cell isolation proteomics | 2019 |
| 60 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
| 61 | PI3K MODULATORS | Identification and characterisation of new class of PI3K modulators in oncology | 2019 |
| 62 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 63 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 64 | PDX-PC | Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer | 2019 |
| 65 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 66 | BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation | 2019 |
| 67 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 68 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 69 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 70 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 71 | ORGANTRANS | Controlled Organoids transplantation as enabler for regenerative medicine translation | 2020 |
| 72 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 73 | oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times | 2020 |
| 74 | CompHematoPathology | Computational Hematopathology for Improved Diagnostics | 2020 |
| 75 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 76 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 77 | ChRONAM-H | Chromatin Regulation Of Normal And Malignant Haematopoiesis | 2020 |
| 78 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |